CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common stock	Additional paid-in capital	Accumulated other comprehensive loss	Accumulated deficit
Beginning balance (in shares) at Dec. 31, 2021		127,647
Beginning balance at Dec. 31, 2021	$ 381,535	$ 128	$ 539,423	$ (237)	$ (157,779)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock (in shares)		35,714
Issuance of common stock	205,296	$ 35	205,261
Share repurchase (in shares)		(130)
Share repurchase	(1,049)		(1,049)
Equity based compensation (in shares)		3
Equity based compensation	3,171	$ 0	3,171
Unrealized gain (loss) on available for sale debt securities	(340)			(340)
Net loss	(25,432)				(25,432)
Ending balance (in shares) at Mar. 31, 2022		163,234
Ending balance at Mar. 31, 2022	563,181	$ 163	746,806	(577)	(183,211)
Beginning balance (in shares) at Dec. 31, 2022		163,550
Beginning balance at Dec. 31, 2022	510,883	$ 164	753,885	(641)	(242,525)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share repurchase (in shares)		(48)
Share repurchase	(277)		(277)
Equity based compensation (in shares)		169
Equity based compensation	2,166	$ 0	2,166
Unrealized gain (loss) on available for sale debt securities	641			641
Net loss	(25,842)				(25,842)
Ending balance (in shares) at Mar. 31, 2023		163,671
Ending balance at Mar. 31, 2023	$ 487,571	$ 164	$ 755,774	$ 0	$ (268,367)